Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Medhora, Meetha ^a   Daniels, John ^a   Mundey, Kavita ^a   Fisslthaler, Beate ^b   Busse, Rudi ^b   Jacobs, Elizabeth R ^a   Harder, David R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cytochrome P 450 2C9; Recombinant adenovirus

Indexed keywords

ADENOVIRUS VECTOR; ARACHIDONIC ACID DERIVATIVE; COMPLEMENTARY DNA; CYTOCHROME P450 2C9; MATRIGEL; MESSENGER RNA;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG; MICROVASCULATURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS RECOMBINANT;

EID: 0037230201     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01118.2001     Document Type: Article

References (55)

1. Alkayed NJ, Goyagi T, Joh HD, Klaus J, Harder DR, Traystman RJ, and Hurn PD. Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke 33: 1677-1684, 2002.
2. Alkayed NJ, Narayanan J, Gebremedhin D, Medhora M, Roman RJ, and Harder DR. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 27: 971-979, 1996.
3. Bondy SC and Naderi S. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem Pharmacol 48: 155-159, 1994.
4. Burns KD, Capdevila J, Wei S, Breyer MD, Homma T, and Harris RC. Role of cytochrome P-450 epoxygenase metabolites in EGF signaling in renal proximal tubule. Am J Physiol Cell Physiol 269: C831-C840, 1995.
5. a. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
6. Chen JK, Capdevila J, and Harris RC. Cytochrome P450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 21: 6322-6331, 2001.
7. Chen JK, Falck JR, Reddy KM, Capdevila J, and Harris RC. Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J Biol Chem 273: 29254-29261, 1998.
8. Chen JK, Wang DW, Falck JR, Capdevila J, and Harris RC. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor. J Biol Chem 274: 4764-4769, 1999.
9. Farin FM, Pohlman TH, and Omiecinski CJ. Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol Appl Pharmacol 124: 1-9, 1994.
10. Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, and Fleming I. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension 36: 270-275, 2000.
11. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
12. Fleming I, Michaelis UR, Bredenkötter D, Fisslthaler B, Dehghani F, Brandes RP, and Busse R. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88: 44-51, 2001.
13. ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J 16: 6439-6451, 1997.
14. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, and Campbell WB. 14,15-Epoxyeicsa-5(Z)-enoic acid a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90: 1028-1036, 2002.
15. Graham FL, Smiley J, Russel WC, and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74, 1977.
16. Graham FL and van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467, 1973.
17. Halcox JP, Narayanan S, Cramer-Joyce L, Mincemoyer R, and Quyyumi AA. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Circ Physiol 280: H2470-H2477, 2001.
18. Hamilton CA, Williams R, Pathi V, Berg G, McArthur K, McPhaden AR, Reid JL, and Dominiczak AF. Pharmacological characterisation of endothelium-dependent relaxation in human radial artery: Comparison with internal thoracic artery. Cardiovasc Res 42: 214-223, 1999.
19. Harder DR, Alkayed NJ, Lange AR, Gebremedhin D, and Roman RJ. Functional hyperemia in the brain: Hypothesis for astrocyte-derived vasodilator metabolites. Stroke 29: 229-234, 1998.
20. + exchange and are mitogenic in cultured rat glomerular mesangial cells. J Cell Physiol 144: 429-437, 1990.
21. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514, 1998.
22. Hoebel BG, Steyrer E, and Graier WF. Origin and function of epoxyeicosatrienoic acids in vascular endothelial cells: More than just endothelium-derived hyperpolarizing factor? Clin Exp Pharmacol Physiol 25: 826-830, 1998.
23. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, and Capdevila JH. Alterations in the regulation of androgen-sensitive CYP4a monooxygenases cause hypertension. Proc Natl Acad Sci USA 98: 5211-5216, 2001.
24. Homma T, Zhang JY, Shimizu T, Prakash C, Blair IA, and Harris RC. Cyclooxygenase-derived metabolites of 8,9-epoxyeicosatrienoic acid are potent mitogens for cultured rat glomerular mesangial cells. Biochem Biophys Res Commun 191: 282-288, 1993.
25. Imig JD, Falck JR, Wei S, and Capdevila JH. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J Vasc Res 38: 247-255, 2001.
26. Ito Y, Iwamoto Y, Tanaka K, Okuyama K, and Sugioka Y. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo. Int J Cancer 67: 148-152, 1996.
27. Jacobs ER and Zeldin DC. The lung HETEs (and EETs) up. Am J Physiol Heart Circ Physiol 280: H1-H10, 2001.
28. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, and Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99: 310-312, 1999.
29. McGrory WJ, Bautista DS, and Graham FL. A simple technique for the rescue of early region-I mutations into infectious human adenovirus type 5. Virology 163: 614-617, 1988.
30. 1-integrin in vascular smooth muscle cells and alters adhesion to fibronectin. Am J Physiol Heart Circ Physiol 279: H382-H387, 2000.
31. Medhora M and Harder D. Functional role of epoxyeicosatrienoic acids and their production in astrocytes: Approaches for gene transfer and therapy. Int J Mol Med 2: 661-669, 1998.
32. Medhora M, Narayanan J, Harder D, and Maier KG. Identifying endothelium-derived hyperpolarizing factor: Recent approaches to assay the role of epoxyeicosatrienoic acids. Jpn J Pharmacol 86: 369-375, 2001.
33. Medhora MM, Okamoto H, Narayanan J, Zhang C, Niu X, Taheri MR, Kraemer R, Capdevila J, and Harder D. Expression of recombinant cytochrome P450 epoxygenase in rat brain. In: EDHF 2000, edited by Vanhoutte PM. London: Taylor & Francis, 2001, chapt. 26, p. 228-238.
34. Medhora MM, Teitelbaum S, Chapel J, Alvarez J, Mimura H, Ross FP, and Hruska KA. 1α-25 hydroxyvitamin D3 upregulates expression of the osteoclast integrin αVβ3. J Biol Chem 268: 1456-1461, 1993.
35. + channels. Circ Res 83: 501-507, 1998.
36. + channels. Circulation 103: 1992-1998, 2001.
37. Munzenmaier DH and Harder DR. Cerebral microvascular endothelial cell tube formation: Role of astrocytic epoxyeicosatrienoic acid release. Am J Physiol Heart Circ Physiol 278: H1163-H1167, 2000.
38. Nishikawa Y, Stepp DW, and Chillian WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol Heart Circ Physiol 277: H1252-H1259, 1999.
39. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, and Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279, 1999.
40. Oltman CL, Weintraub NL, VanRollins M, and Dellsperger KC. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 83: 932-939, 1998.
41. Park JE, Chen HH, Winer J, Houck KA, and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269: 25646-25654, 1994.
42. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, and Martin GR. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67: 519-528, 1992.
43. Quilley J and McGiff JC. Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 21: 121-124, 2000.
44. Sagawa K, Swaim W, Zhang J, Unsworth E, and Siraganian RP. Aggregation of the high affinity IgE receptor results in the tyrosine phosphorylation of the surface adhesion protein PECAM-1 (CD31). J Biol Chem 272: 13412-13418, 1997.
45. Sellmayer A, Uedelhoven WM, Weber PC, and Bonventre JV. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J Biol Chem 266: 3800-3807, 1991.
46. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, and Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28: 703-711, 1996.
47. Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Schwartzman ML. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors. J Pharmacol Exp Ther 284: 966-973, 1998.
48. Weintraub NL, Fang X, Kaduce TL, VanRollins M, Chatterjee P, and Spector AA. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. CircRes 81: 258-267, 1997.
49. Werck-Reichhart D and Feyereisen R. Cytochromes P450: a success story. Genome Biol 1: 3003.1-3003.9, 2000.
50. Wu S, Chen W, Murphy E, Gabel S, Tomer KB, Foley J, Steenbergen C, Falck JR, Moomaw CR, and Zeldin DC. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272: 12551-12559, 1997.
51. Yang B, Graham L, Dikalov S, Mason RP, Falck JR, Liao JK, and Zeldin DC. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60: 310-320, 2001.
52. Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276, 36059-36062, 2001.
53. Zeldin DC, DuBois RN, Falck JR, and Capdevila JH. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys 322: 76-86, 1995.
54. Zeldin DC, Plitman JD, Kobayashi J, Miller RF, Snapper JR, Falck JR, Szarek JL, Philpot RM, and Capdevila JH. The rabbit pulmonary cytochrome P-450 arachidonic acid metabolic pathway: Characterization and significance. J Clin Invest 95: 2150-2160, 1995.
55. Zhang CZ and Harder DR. Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic-epoxyeicosatrienoic acid. Stroke. In press.